Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;24(4):682-694.
doi: 10.1016/j.jfda.2016.08.001. Epub 2016 Sep 10.

7-N-Acetylcysteine-pyrrole conjugate-A potent DNA reactive metabolite of pyrrolizidine alkaloids

Affiliations

7-N-Acetylcysteine-pyrrole conjugate-A potent DNA reactive metabolite of pyrrolizidine alkaloids

Xiaobo He et al. J Food Drug Anal. 2016 Oct.

Abstract

Plants containing pyrrolizidine alkaloids (PAs) are widespread throughout the world and are the most common poisonous plants affecting livestock, wildlife, and humans. PAs require metabolic activation to form reactive dehydropyrrolizidine alkaloids (dehydro-PAs) that are capable of alkylating cellular DNA and proteins, form (±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine (DHP)-DNA and DHP-protein adducts, and lead to cytotoxicity, genotoxicity, and tumorigenicity. In this study, we determined that the metabolism of riddelliine and monocrotaline by human and rat liver microsomes in the presence of N-acetylcysteine both produced 7-N-acetylcysteine-DHP (7-NAC-DHP) and DHP. Reactions of 7-NAC-DHP with 2'-deoxyguanosine (dG), 2'-deoxyadenosine (dA), and calf thymus DNA in aqueous solution followed by enzymatic hydrolysis yielded DHP-dG and/or DHP-dA adducts. These results indicate that 7-NAC-DHP is a reactive metabolite that can lead to DNA adduct formation.

Keywords: 7-N-acetylcysteine-DHP; DHP; LC-ES-MS/MS; pyrrolizidine alkaloid.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structures of PAs, dehydro-PAs, DHP, DHP-dG-1, DHP-dG-2, DHP-dG-3, DHP-dG-4, DHP-dA-1, DHP-dA-2, DHP-dA-3, and DHP-dA-4 adducts. dA = 2′-deoxyadenosine, dG = 2′-deoxyguanosine, DHP =(±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, PA = pyrrolizidine alkaloids.
Figure 2
Figure 2
HPLC profiles of 7-NAC-DHP and DHP obtained from (A) organic synthesis; and from metabolism of riddelliine in the presence of N-acetylcysteine by (B) male human liver microsomes; (C) male rat liver microsomes; and (D) male rat liver microsomes without the addition of NADPH. DHP =(±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, HPLC = high performance liquid chromatography, NAC = N-acetylcysteine.
Figure 3
Figure 3
Electrospray positive ion/product ion mass spectra of 7-NAC-DHP from (A) organic synthesis; and in the chromatographic peak eluting at 28.85–29.25 minutes in Fig. 2 obtained from the results of the metabolism of riddelliine in the presence of N-acetylcysteine by (B) male human liver microsomes; (C) male rat liver microsomes; and (D) male rat liver microsomes without the addition of NADPH. The product ions of the [M – H2O + H]+ m/z 281 were acquired with a collision energy of 10 eV. DHP =(±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, NAC = N-acetylcysteine.
Figure 4
Figure 4
Electrospray positive ion/product ion mass spectra of DHP from (A) organic synthesis; and in the chromatographic peak eluting at 25.3 minutes in Fig. 2 obtained from the metabolism of riddelliine in the presence of N-acetylcysteine by (B) male human liver microsomes; (C) male rat liver microsomes; and (D) male rat liver microsomes in the absence of NADPH, The product ions of the [M – H2O + H]+ m/z 136 were acquired with a collision energy of 22 eV. DHP = (±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine.
Figure 5
Figure 5
HPLC profiles of 7-NAC-DHP and DHP from (A) organic synthesis; and from metabolism of monocrotaline in the presence of N-acetylcysteine by (B) male human liver microsomes; and (C) male rat liver microsomes. DHP =(±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, NAC = N-acetylcysteine.
Figure 6
Figure 6
Electrospray positive ion/product ion mass spectra of 7-NAC-DHP from (A) organic synthesis; and in the chromatographic peak eluting at 28.85–29.25 minutes in Fig. 5 obtained from the metabolism of monocrotaline in the presence of N-acetylcysteine by (B) male human liver microsomes; and (C) male rat liver microsomes. The product ions of the [M – H2O + H]+ m/z 281 were acquired with a collision energy of 10 eV. DHP =(±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, NAC = N-acetylcysteine.
Figure 7
Figure 7
Electrospray positive ion/product ion mass spectra of DHP from (A) organic synthesis; and in the chromatographic peak eluting at 25.3 minutes in Fig. 5 obtained from the metabolism of monocrotaline in the presence of N-acetylcysteine by (B) male human liver microsomes; and (C) male rat liver microsomes. The product ions of the [M – H2O + H]+ m/z 136 were acquired with a collision energy of 22 eV. DHP = (±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine.
Figure 8
Figure 8
HPLC profiles of reactions of 7-NAC-DHP with dG and dA for 1, 3, and 5 days: (A–C) detection of DHP-dG adducts monitored at 256 nm; and (D–F) detection of DHP-dA adducts monitored at 269 nm. For reaction conditions, see Materials and methods section. dA = 2′-deoxyadenosine, dG = 2′-deoxyguanosine, DHP = (±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine.
Figure 9
Figure 9
The formation of DHP-dG and DHP-dA adducts from reaction of 7-NAC-DHP with calf thymus DNA for 1, 3, and 5 days. dA = 2′-deoxyadenosine, dG = 2′-deoxyguanosine, DHP =(±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, NAC = N-acetylcysteine.
Figure 10
Figure 10
LC/MS SRM chromatograms of DHP-dG and DHP-dA adducts formed from the reaction of 7-NAC-DHP with calf thymus DNA for 3 days. dA = 2′-deoxyadenosine, dG = 2′-deoxyguanosine, DHP =(±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, IS = DHP-[15N5]dG and DHP-[15N5, 13C10]dA labeled internal standards, LC/MS = liquid chromatography/mass spectrometry, NAC =N-acetylcysteine, SRM = selected reaction monitoring.
Figure 11
Figure 11
The proposed general metabolic activation pathways leading to the formation of DNA adducts and the potential initiation of PA-induced liver tumors. dA = 2′-deoxyadenosine, dG = 2′-deoxyguanosine, DHP =(±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, NAC =N-acetylcysteine, PA = pyrrolizidine alkaloids.

References

    1. Edgar JA, Molyneux RJ, Colegate SM. Pyrrolizidine alkaloids: potential role in the etiology of cancers, pulmonary hypertension, congenital anomalies, and liver disease. Chem Res Toxicol. 2015;28:4–20. - PubMed
    1. Fu PP, Chou MW, Xia Q, Yang Y-C, Yan J, Doerge DR, Chan PC. Genotoxic pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides—mechanisms leading to DNA adduct formation and tumorigenicity. J Environ Sci Health, Part C. 2001;19:353–85.
    1. Fu PP, Xia Q, Lin G, Chou MW. Pyrrolizidine alkaloids–genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev. 2004;36:1–55. - PubMed
    1. Fu PP, Yang Y-C, Xia Q, Chou MW, Cui YY, Lin G. Pyrrolizidine alkaloids – tumorigenic components in Chinese herbal medicines and dietary supplements. J Food Drug Anal. 2002;10:198–211.
    1. Huxtable RJ. In: Human health implications of pyrrolizidine alkaloids and herbs containing them. Cheeke PR, Alkaloids I, editors. Boca Raton, FL: CRC Press; 1989. pp. 41–86.

LinkOut - more resources